Moderna said Friday that the European Patent ... rival COVID-19 vaccines. Cambridge-based Moderna has been fighting Pfizer and BioNTech in the courts over the partners’ COVID shot, called ...
WARMINSTER, PA — Arbutus Biopharma Corporation recently announced a favorable outcome in its ongoing patent ... of the case, ...
The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious dispute between the company ...
Pfizer and partner BioNTech have launched a countersuit against Moderna in a patent ... and COVID-19 vaccines entered regular commercial trade with producers competing for the booster shot market ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe May 17, 2024 Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic ...
Demand for its COVID vaccine has been waning since the pandemic, while adoption of its RSV shot - its second approved product- has been slower than expected, forcing Moderna to cut costs.
Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and COVID-19 cases in the U.S. following the latest ...
The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent ...